Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF vs rhG-CSF for Neutropenia Prophylaxis in Lymphoma
NCT04083079Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
A Phase 4 trial of pegfilgrastim in neutropenia, sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT04083079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083079.